FDA approves NPS Pharma's bowel syndrome drug but with a rider
(Reuters) - U.S. health regulators approved NPS Pharmaceuticals Inc's short bowel syndrome drug Gattex, but asked the company to conduct a post-market...
Source: http://goo.gl/mag/USIWtBR
No comments:
Post a Comment